Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Transmission and prevention news

Show

From To
Brazil to make PrEP available to populations at highest risk of HIV infection

Brazil will make the HIV preventative drug, PrEP (pre-exposure prophylaxis), available to populations at highest risk of HIV infection. This includes sex workers, mixed HIV-status couples, transgender people and gay and bisexual men.

Published
26 May 2017
From
Gay Star News
Facing our fears: What does news of a possible PrEP failure mean?

In light of recent reports of a person becoming HIV positive while using PrEP, our community’s collective response can inform the future of HIV prevention and sexual health promotion in Australia. While HIV/AIDS organisations and community groups are leading the way to allay public concerns, we address some of the questions surrounding this unusual event.

Published
26 May 2017
From
Emen8
PrEP 17 – The coming of age of PrEP

PrEP17 explores the stories of over a dozen PrEP activists; current and former PrEP users; clinicians; and policy-makers. The 36 minute documentary film, commissioned by PrEPster, shines a light on how PrEP has become available to thousands of people, despite the failures of the health system.

Published
26 May 2017
From
Prepster
HIV 'fingerprint' tool could greatly assist vaccine development

A method that quickly fingerprints the shield of sugar molecules that helps HIV evade immune system antibodies could be very useful to vaccine developers.

Published
26 May 2017
From
HIV / AIDS News From Medical News Today
Heroin combined with fentanyl is driving overdose crisis in US

New sources of heroin and increasing adulteration with fentanyl and other stronger analogues are contributing to a growing epidemic of opioid overdose deaths in several regions of

Published
24 May 2017
By
Liz Highleyman
Inovio HIV Vaccine Elicits Nearly 100% Immune Response Rates in a Clinical Study

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that its HIV vaccine, PENNVAX®-GP, produced amongst the highest overall levels of immune response rates (cellular and humoral) ever demonstrated in a human study by an HIV vaccine.

Published
24 May 2017
From
Inovio press release
Indonesian buyers club helps people obtain generic hepatitis C treatment

A community-led buyers club in Indonesia has helped more than 100 people get generic direct-acting antiviral (DAA) drugs to treat hepatitis C and is seeing a high

Published
24 May 2017
By
Liz Highleyman
Injecting drug use increases worldwide, but no increases in needle and syringe programmes

Despite reports of expanding rates of injecting drug use in a new list of countries around the world, no new countries have established needle and syringe programmes

Published
24 May 2017
By
Susie McLean
Pet care can connect people to health and harm reduction services

Providing free veterinary care can be a good way to bring homeless and marginally housed people into contact with health care, harm reduction and other services, according

Published
24 May 2017
By
Liz Highleyman
Philadelphia HIV Activist Paul Yabor Dies at 55

Paul Yabor, an HIV activist who spent much of his time helping injection drug users and advocating safe spaces for that community, passed away last week in Philadephia. He was 55.

Published
24 May 2017
From
The Body
← First12345...531Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.